About this trial
This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. All cancer survivors stand to benefit from electronic health record innovations, as they can experience profound pain outcomes, including marked under- and over-prescribing of opioids. Digitally facilitated solutions are especially helpful and can be customized to address patient needs. The ASCENT intervention provides patients with an educational guide that describes techniques for addressing cancer pain, and uses community health workers and pain care managers to coach patients through a personalized pain management plan. This study may help researchers learn how pain management strategies can improve cancer pain and lower risk of opioid exposure and dependency in cancer survivors.
Eligibility criteria
Qualifiers
A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site in the past 15 years
Including malignant hematology
Lymphoma
Myeloma
Disqualifiers
Patient Health Questionnaire - 8 (PHQ8) score of >= 13
Hospice enrollment
Skilled nursing facility, inpatient rehabilitation facility, or long-term care placement
Encounters with Palliative Care or the Pain Clinic in the past two months or upcoming two months
Trial design
Treatments tested in this trial
- Best Practice
- Educational Intervention
- Questionnaire Administration
- Electronic Health Record Review
- Health Telemonitoring
- Cancer Pain Management
Treatment groups
Sponsors and collaborators
Mayo Clinic
Lead sponsor
National Cancer Institute (NCI)
Collaborator